Research & Development
Skin Cancer: Page 2
SkylineDx, Mayo Clinic evaluate genetic skin cancer test
The test can accurately predict the risk of regional metastasis at the time of melanoma diagnosis, according to SkylineDx.
September 25, 2019
Castle Biosciences moves ahead with skin cancer test
In a study of data drawn from patients at 18 centers, researchers identified a preliminary set of genes and developed a predictive algorithm associated with significantly higher risk for the recurrence of cSCC, a nonmelanoma type of skin cancer. The positive predictive value of the prognostic test was 60%, a result the company said compares well with current staging methods.
May 7, 2019
Page 2 of 2